Mission Creek Capital Partners’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$560K Sell
1,057
-114
-10% -$52.6K 0.1% 137
2026
Q1
$562K Buy
1,171
+348
+42% +$178K 0.11% 139
2025
Q4
$462K Buy
+823
New +$467K 0.09% 142

Other funds holding MEDP

Mission Creek Capital Partners's MEDP Position: Q2 2026 in Review

Mission Creek Capital Partners reduced its Medpace (MEDP) stake by 9.7% in Q2 2026, selling an estimated $52.6K and leaving 1,057 shares worth $560K. The position accounts for 0.1% of the portfolio, ranked #137.

Mission Creek Capital Partners first reported a position in MEDP in Q4 2025 and has held it in 3 quarters since. The position peaked at $562K in Q1 2026. 699 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Mission Creek Capital Partners held 1,057 shares of Medpace worth $560K as of Q2 2026.
  • Mission Creek Capital Partners sold 114 Medpace shares in Q2 2026, an estimated $52.6K.
  • Medpace made up 0.1% of Mission Creek Capital Partners's portfolio in Q2 2026, its #137 holding.
  • Mission Creek Capital Partners first reported a position in Medpace in Q4 2025 and has held it in 3 quarters since.
  • Mission Creek Capital Partners's Medpace position peaked at $562K in Q1 2026.
  • 699 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Mission Creek Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.